ArticleFrontiers in oncology2023
TOMM34 serves as a candidate therapeutic target associated with immune cell infiltration in colon cancer.
Zhigui Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it